Agenda
Join us on Tuesday, February 28th as we kick-off the conference with our Feeding the Pipeline series. You will hear discussions from leaders of five of the most productive research institutes in the US.
*Agenda below is subject to change and not yet finalized.
Tuesday, February 25
Outing at Torrey Pines Golf Course
Kick off the 15th Annual Global Life Science Partnering & Investor Conference with a round at the legendary Torrey Pines Golf Course. As an added benefit for our conference attendees, Biocom has secured a limited number of tee times at Torrey Pines Golf Course, the proud site of the PGA TOUR’s annual Farmers Insurance Open and the 2008 and 2021 U.S. Open Championships. Additional details coming soon.
Conference Registration Open
Conference registration will remain open throughout the entirety of the conference.
1:1 Partnering Meetings Open
The Global Life Science Partnering & Investor Conference utilizes BIO’s One-on-One Partnering System. Participating in One-on-One Partnering at the Global Life Science Partnering & Investor Conference is the most efficient way to do business in the biotech and pharma industry in a virtual environment. The system makes it easy to search for and identify potential partners and request and schedule meetings with prospective biotech investors and senior business development executives.
Welcome Remarks
Speakers
James Schaeffer, Ph.D.
Vice President, Business Strategy, PhenoTarget
Feeding the Pipeline
Our 15th annual conference will kick off with a dynamic panel discussion between leaders from Blackbird Laboratories, Cedars-Sinai Medical Center, Scripps Research and the Stanford University School of Medicine. Don’t miss your opportunity to get an early glimpse of the hottest discoveries within these innovation hubs.
Speakers
Ben Cravatt, Ph.D.
Professor & Gilula Chair, Chemical Biology, The Scripps Research Institute
Thomas Daniel, M.D.
Director, Scripps Research; Chair & Founder, Life Science Cares San Diego
Shlomo Melmed, M.D.
Dean, Cedars-Sinai Medical Center
Daria Mochly-Rosen, Ph.D.
Founder, SPARK at Stanford & The George D. Smith Professor of Translational Medicine, Stanford University School of Medicine
Matt Tremblay, Ph.D.
Chief Executive Officer, Blackbird Laboratories
Networking Lunch
Keynote Session
Speakers
Kate Bingham
Managing Partner, SV Health Investors
John Lepore, M.D.
CEO, ProFound Therapeutics; CEO-Partner, Flagship Pioneering
The Evolving Landscape of Drug Discovery Targeting RNA
Speakers
Sarah Boyce
President & CEO, Avidity Biosciences
Richard Heyman, Ph.D.
Venture Partner, ARCH Ventures
Brett Monia, Ph.D.
CEO, Ionis Pharmaceuticals
Amir Nashat, Ph.D.
Board Chair, Paratus Sciences; Managing Partner, Polaris Partners
AI & Drug Discovery: It’s Not As Easy As It Looks
Six years after Alpha Fold initiated the AI revolution in biotech, this panel will take stock of progress and disappointments to date and survey the ambitions driving entrepreneurs and pharmas into the decade ahead.
Speakers
Bill Martin, Ph.D.
Global Therapeutic Area Head, Neuroscience, Johnson & Johnson Innovative Medicine
Thomas Miller
Co-Founder & CEO, Iambic Therapeutics
Mary Rozenman, Ph.D.
CFO & CBO, insitro
Marc Tessier-Lavigne, Ph.D.
Co-Founder, Chairman & CEO, Xaira Therapeutics
D.A. Wallach
Co-Founder & General Partner, Time BioVentures
Venture Capital Trends: Funding the Future of Life Science
Speakers
Jeremy Caldwell, Ph.D.
Managing Director, Red Tree Venture Capital
Shelley Chu, M.D., Ph.D.
Partner, Lightspeed Ventures
Jay Lichter, Ph.D.
Managing Director, Avalon Ventures
Carolyn Ng, Ph.D.
Partner & Managing Director, TPG Life Sciences Innovations
Camille Samuels
Director, Venrock Boards
Court Turner
Partner, LYZZ Capital
Welcome Reception
Following our afternoon panel discussions, Biocom invites you to a welcome reception at The Lodge at Torrey Pines. This reception provides an excellent opportunity to network with conference attendees and speakers, as well as gain exclusive access to the delegates visiting San Diego from all over the globe.
Wednesday, February 26
Breakfast & Networking
We invite you to join us for a networking breakfast before our first session of the day. We encourage you to arrive by 8:15 a.m. to ensure you get a seat in time for the sessions kicking off at 8:30 a.m.
Conference Registration Open
The registration desk will remain open throughout the entirety of the conference.
1:1 Partnering Meetings Open
The Global Life Science Partnering & Investor Conference utilizes BIO’s One-on-One Partnering System. Participating in One-on-One Partnering at the Global Life Science Partnering & Investor Conference is the most efficient way to do business in the biotech and pharma industry in a virtual environment. The system makes it easy to search for and identify potential partners and request and schedule meetings with prospective biotech investors and senior business development executives.
Morning Remarks with Biocom
Join us as we kick off day two of our conference with welcome remarks from Biocom’s incoming CEO, Tim Scott.
Founding Co-Chair Remarks
Speakers
Jennifer Giottonini Cayer
Chief Business Officer, Pulmocide
The Power Players: Big Pharma’s Approach to Partnering & Growth
Speakers
Devang Bhuva
Senior Vice President, Corporate Development, Gilead Sciences
Rachna Khosla
Senior Vice President, Business Development, Amgen
Sunil Patel
Head of Corporate Development and Business Development & Licensing, Merck
Jay Stamatis
CEO, MBrace Therapeutics
Coffee & Networking Break
Fireside Chat
Speakers
Steven Paul, M.D.
Board Chair, FNIH; Venture Partner, Third Rock Ventures
James Schaeffer, Ph.D.
Vice President, Business Strategy, PhenoTarget
Company Presentations: Accepting Applications
Our Global Life Science Partnering & Investor Conference will include multi-track company presentation sessions which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance. Company presentation applications are open now through Friday, January 10. Apply today to seize your spotlight.
Networking Lunch
Join us for a networking lunch overlooking the world famous Torrey Pines golf course.
Capital Markets Update
Venture Investing in 2025
Speakers
Shawna Frazier
Director, West Coast Ventures, AbbVie
Luba Greenwood
CEO, Mwyngil Therapeutics
Jason Hafler, Ph.D.
Managing Director, Sanofi Ventures
Mitchell Mutz, Ph.D.
Entrepreneur Partner, Vivo Capital
Carole Nuechterlein
Head, Roche Venture Fund
Daniel O’Connell, M.D., Ph.D.
Partner, Novo Ventures
Company Presentations: Accepting Applications
Our Global Life Science Partnering & Investor Conference will include multi-track company presentation sessions which provide a stage for emerging life science companies to showcase their latest innovations and gain additional exposure to investors and potential strategic partners in attendance. Company presentation applications are open now through Friday, January 10. Apply today to seize your spotlight.
The Future of Big Pharma: Navigating Innovation & Collaboration
Speakers
Detlev Mennerich, Ph.D.
Global Head, Boehringer Ingelheim Venture Fund
Mark Paris, Ph.D.
Executive Director, Oncology Search and Evaluation, Daiichi Sankyo
Jeremy Quirk
VP BD&L Commercial Portfolio, GSK
Avi Spier, Ph.D.
Executive Director, Search & Evaluation, Novartis
Gala Networking Reception
Unwind from a day of enriching sessions and one-on-one partnering meetings while taking in the breathtaking views of the world-famous Torrey Pines Golf Course at our Gala Networking Reception on the outdoor lawn. Often hailed as the highlight of the conference, this evening reception promises great company, delicious bites and a fully hosted cocktail and mocktail bar ensuring everyone can raise a glass to success. Friendly Reminder: While San Diego is known for its great weather, please prepare to be outside as colder weather is anticipated.
Thursday, February 27
1:1 Partnering Meetings Open
The Global Life Science Partnering & Investor Conference utilizes BIO’s One-on-One Partnering System. Participating in One-on-One Partnering at the Global Life Science Partnering & Investor Conference is the most efficient way to do business in the biotech and pharma industry in a virtual environment. The system makes it easy to search for and identify potential partners and request and schedule meetings with prospective biotech investors and senior business development executives.
Conference Registration Open
The registration desk will remain open for the entirety of the conference.
Breakfast & Networking
We invite you to join us for a networking breakfast before our first session of the day three.
Welcome Remarks
Speakers
Jennifer Giottonini Cayer
Chief Business Officer, Pulmocide
Fireside Chat
Speakers
Jennifer Giottonini Cayer
Chief Business Officer, Pulmocide
John Hood, Ph.D.
Founder, CEO & Executive Chairman, Endeavor BioMedicines
Coffee & Networking Break
Big Pharma’s Blueprint for Success
Speakers
Tim Luker, Ph.D.
Vice President, Lilly Ventures, West Coast USA Head, Corp BD, Eli Lilly
Tari Suprapto, Ph.D.
Senior Director, Head of Search, Novo Nordisk
Fan Zhang, Ph.D.
Vice President of Business Development, Bristol Myers Squibb
Going Public: The Life Science IPO Journey
Speakers
Kent Hawryluk
President & CEO, MBX Biosciences
Networking Lunch
Mergers & Acquisitions
Speakers
Kevin Lind
President & CEO, Longboard Pharmaceuticals
Ken Song, M.D.
Chairman, President & CEO, Candid Therapeutics
Today’s VC Environment
Speakers
Mira Chaurushiya, Ph.D.
Managing Director, Westlake Village BioPartners
Richard Glynne, Ph.D.
Acting CEO, Belharra Therapeutics; President & CSO, Inception Therapeutics Discovery Engine; Venture Partner, Versant Ventures
Corey Goodman, Ph.D.
Managing Partner, venBio Partners
Tony Ho
Chief Scientific Officer & Senior Science Partner, Pivotal Life Sciences
Nina Kjellson
General Partner, Canaan Partners
Deborah Palestrant, Ph.D.
Partner & Executive Chair, 4:59 Initiative, 5AM Ventures
Closing Remarks from Conference Co-Chairs
Speakers
Igor Bilinsky, Ph.D.
Chief Operating Officer, Iovance Biotherapeutics
Jennifer Giottonini Cayer
Chief Business Officer, Pulmocide
James Schaeffer, Ph.D.
Vice President, Business Strategy, PhenoTarget
Mark Wiggins
Chief Business Officer, Vaxcyte
Closing Reception
Join us for complimentary drinks and hors d’oeuvres immediately following the closing session of the conference. Don’t miss the opportunity to make those last connections with attendees and speakers before leaving sunny San Diego.